Cargando…
Visceral Adiposity as a Significant Predictor of Sunitinib-Induced Dose-Limiting Toxicities and Survival in Patients with Metastatic Clear Cell Renal Cell Carcinoma
SIMPLE SUMMARY: Although sunitinib is a standard first-line treatment for metastatic renal cell carcinoma, little is known about the predictive factors of sunitinib-induced dose-limiting toxicity in Asian populations. Thus, the aim of this study was to determine whether body composition features sig...
Autores principales: | Park, Jee Soo, Koo, Kyo Chul, Chung, Doo Yong, Kim, Sun Il, Kim, Jeongho, Oh, Cheol Kyu, Kim, Tae Nam, Kang, Sung Ku, Park, Jae Won, Yoon, Young Eun, Park, Sung Yul, Rha, Koon Ho, Ham, Won Sik |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7761595/ https://www.ncbi.nlm.nih.gov/pubmed/33276522 http://dx.doi.org/10.3390/cancers12123602 |
Ejemplares similares
-
Association between visceral adiposity and DDX11 as a predictor of aggressiveness of small clear-cell renal-cell carcinoma: a prospective clinical trial
por: Park, Jee Soo, et al.
Publicado: (2021) -
Predictive value of preoperative monocyte–lymphocyte ratio among patients with localized clear renal cell carcinoma of ≤7 cm on preoperative imaging
por: Elghiaty, Ahmed, et al.
Publicado: (2018) -
The DEAD/DEAH Box Helicase, DDX11, Is Essential for the Survival of Advanced Clear Cell Renal Cell Carcinoma and Is a Determinant of PARP Inhibitor Sensitivity
por: Park, Jee Soo, et al.
Publicado: (2021) -
Prediction of High-Grade Clear Cell Renal Cell Carcinoma Based on Plasma mRNA Profiles in Patients with Localized Pathologic T1N0M0 Stage Disease
por: Park, Jee Soo, et al.
Publicado: (2020) -
A Unique Instrumental Malfunction during Robotic Prostatectomy
por: Park, Sung Yul, et al.
Publicado: (2010)